Verdict: NextPharma demonstrates explicit commitment to customer-centricity and has published evidence of a structured Net Promoter Score programme on its public About page. The company names NPS as a measurement discipline and references listening mechanisms and feedback-driven improvement. However, public evidence is thin—limited to two pages crawled—and lacks specificity about B2B customer segments, actual NPS results, or concrete examples of how feedback has shaped product or service delivery. The overall score of 8.0 reflects the presence of foundational CX language and named metrics, but the shallow density of customer-focused narrative suggests the programme may be mature internally but under-communicated externally.
B+
8 / 10
Good — meaningful CX commitment
Scorecard
💬Customer language
3 / 3
NextPharma uses customer-related terms sparingly across limited public pages; references to 'customers,' 'listening,' and 'partnership' appear but are not densely woven into the narrative.
🔄CX programme evidence
3 / 3
The company explicitly names customer satisfaction, listening, and Net Promoter Score as disciplines, placing it at entry-to-mid level for CX maturity signals.
📊Measurement proof
2 / 3
NPS is named directly on the About page as a structured feedback method, meeting the threshold for explicit metric mention but with no published scores, targets, or trend data.
🤝Commitment depth
0 / 1
No evidence of tailored language, case studies, or messaging that addresses the specific needs, pain points, or industry challenges of pharmaceutical development or manufacturing buyers.
Overall score
The overall score reflects the presence of credible NPS messaging balanced against thin evidence density and absence of B2B differentiation or results transparency.
8/10
Evidence
Sorted by rubric tier descending — Tier 3 (named measurement) and Tier 4 (commitment depth) are the rarest and most differentiating signals. A single source page may satisfy several criteria (e.g. [T3a] + [T3b] + [T3c] stacked).
[T3a] NPS, CSAT, or named metric explicitly mentioned[T3b] Named metric on a public web page (not only in PDF)StrongView ↗
of development, manufacturing, and supply. We measure customer loyalty and partnership strengths through structured feedback methods, including the 'Net Promoter Score' (NPS), as well as operational…
[T2a] CX named as a discipline[T2b] Customer listening or feedback mechanism[T2c] Acting on feedback or CX in reportingMediumView ↗
d our customer dedication Customer satisfaction is our key commitment with our day to day dedication to be the best performer in the following areas: Customer focused reputation Synergies between pro…
[T1a] Customer or client mentioned[T1b] Customer language on 2+ page types[T1c] Operational customer languageWeakView ↗
Our vision is to be the leading and most trusted, reliable and innovative Europe-based CDMO by upholding the highest industry standards and exceeding customer expectations, while driving strong, sust…
[T1a] Customer or client mentioned[T1b] Customer language on 2+ page types[T1c] Operational customer languageWeakView ↗
n this year. View all News and Events A growing CDMO with profitable and competitive services Continuous organic growth supported by strong levels of customer trust, and inorganic growth through acqu…
What NextPharma is doing well
NextPharma explicitly names Net Promoter Score on its About page and describes a structured approach to measuring 'customer loyalty and partnership strengths.' This signals that the company runs a formalised feedback programme, not just ad-hoc surveys, and has chosen to make that discipline public—a maturity indicator in the CDMO sector.
The company articulates a closed-loop mindset: it listens to customers, identifies where improvements can be made, and commits to delivering a 'stronger experience' in development, manufacturing, and supply. This language moves beyond sentiment collection to imply action, which is a positive signal for programme credibility.
NextPharma frames customer dedication and satisfaction as key commitments embedded in daily operations, suggesting NPS and CX are not marketing afterthoughts but operational priorities aligned with the business model of a contract manufacturer.
What is missing
No published NPS score, benchmark, or trend data appears on the public website. Competitors and prospects cannot see whether NextPharma's NPS is improving, how it compares to industry peers, or what score thresholds define success. This opacity undermines the credibility of the programme and leaves the claim unverified.
B2B specificity is absent. NextPharma does not speak to the distinct needs of its customer base—pharmaceutical sponsors, biotech firms, or regulatory bodies—or show how NPS and customer feedback inform product development, manufacturing reliability, or supply-chain resilience. Generic customer language does not resonate with buyers evaluating CDMO partners.
Analyst implication: NextPharma has a live NPS programme but keeps its results and impact hidden; refreshing public evidence with actual scores, customer testimonials, and feedback-driven case studies would substantially strengthen market positioning and trust.
How NextPharma could improve its ranking
Publish an actual or anonymised NPS score (e.g., 'Our latest Net Promoter Score is 65, reflecting strong satisfaction among our pharma and biotech partners') alongside a brief narrative of what drives it and how the company is tracking progress. This moves NextPharma from claiming a programme to demonstrating confidence in its results.
Add 2–3 customer-impact examples to the About page: how customer feedback shaped a manufacturing process improvement, accelerated regulatory compliance, or reduced time-to-market. These stories translate NPS discipline into tangible buyer value and are far more persuasive than generic CX language.
Suggested website text
Want to improve this grade?
See what world-class customer-centricity looks like and what changes would move the needle for NextPharma.
Recommended copy · About Us page · Net Promoter Score version
Customer Experience is a Strategic Priority: We do more than collect feedback — we act on it. Our closed-loop feedback discipline ensures every client voice drives measurable improvement across our products and services. We measure customer loyalty using the Net Promoter Score (NPS) and are committed to sharing our progress publicly as part of our transparency commitment.
💡 Why this improves your score: Adding the actual NPS number (e.g. 'Our 2025 NPS reached 72') would award T3c (+2 points) and significantly improve NextPharma's Customer Test ranking. This single addition could move the grade from B to A.
See full scoring methodology →
Research note: We may have been unable to view all website material for this company.
Some evidence may be absent.
If you wish to add evidence,
please use this form.
Legal Disclaimer — DISCLAIMER: TheCustomerTest provides independent, editorial analysis based on publicly available documents and information. All scores, ratings, and commentary reflect subjective opinions derived from our methodology and are not statements of fact. Where customer metrics such as Net Promoter Score (NPS) or CSAT are referenced, they are not evaluated on their absolute value, but rather as evidence of transparency in measurement and a company's efforts to understand and improve customer experience. While we aim to use reliable sources, we make no representations regarding the accuracy, completeness, or timeliness of the content. We are not affiliated with, endorsed by, or sponsored by any of the companies referenced. This website's content is for informational purposes only and does not constitute professional advice. Users should not rely solely on these assessments for business decisions. To the fullest extent permitted by law, we disclaim all liability for any loss arising from use of this site, and we reserve the right to update or remove content at any time.
